Records containing: Purpura, Thrombocytopenic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-31ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
-
CLINICAL_TRIALS study record update · 2025-09-16A Multicenter, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523, a Syk Inhibitor, in Adult Subjects With Immune Thrombocytopenia
-
CLINICAL_TRIALS study record update · 2024-05-29Development Of Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry (REPTT): A Study Proposal Of The Spanish Society Of Hematology And Hemotherapy (SEHH) Whit The Portuguese Society Of Hematology (SPH)
-
CLINICAL_TRIALS study record update · 2022-11-28Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
-
CLINICAL_TRIALS study record update · 2021-09-05A Single-center Prospective Randomized Study of Atorvastatin in the Treatment of Newly Diagnosed Primary Immune Thrombocytopenia (ITP)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-05-13ClinicalTrials.gov study NCT00005302
-
CLINICAL_TRIALS study record update · 2010-04-21Screening Protocol and Longitudinal Study of Bone Marrow Failure Syndromes and Cytopenias
-
CLINICAL_TRIALS study record update · 2008-09-10ClinicalTrials.gov study NCT00010387